Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells (Q34473395)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells (English)

1 reference

Europe PubMed Central

2 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

prostaglandin E2

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

author name string

Chang Han

1

1 reference

Europe PubMed Central

2 August 2017

George K Michalopoulos

2

1 reference

Europe PubMed Central

2 August 2017

Tong Wu

3

1 reference

Europe PubMed Central

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2006

1 reference

Europe PubMed Central

2 August 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

2 August 2017

207

1 reference

Europe PubMed Central

2 August 2017

261-270

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

1 reference

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M500562200

30 December 2023

Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ce

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M404852200

Prostanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

EGFR signal transactivation in cancer cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Elevated levels of prostaglandin E2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Genetic and pharmacological analysis of prostanoid receptor function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Malignant transformation and EGFR activation of immortalized mouse liver epithelial cells caused by HBV enhancer-X from a human hepatocellular carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Transactivation joins multiple tracks to the ERK/MAPK cascade

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Inhibitory effect of the non-steroidal anti-inflammatory drugs, indomethacin and piroxicam on 2-acetylaminofluorene-induced hepatocarcinogenesis in male ACI/N rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prostanoid receptors: subtypes and signaling

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/JCP.20560

Identifiers

10.1002/JCP.20560

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

reason for deprecated rank

unchecked identifier

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34473395&oldid=2073456456"